Re: ZHCLF trades on the OTC
in response to
by
posted on
Jan 18, 2021 03:03PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
In the buyout scenario, this better not be the case as my CUSIP # on the shares is the same and I better be entitled to a payout. I have held these shares since the split from RVX and only recently did I see it trade with a value. I remain holding until a buyout scenario (which is hopefully soon).